ReviewFEMS microbiology reviews2026
Emerging strategies of bacterial adaptation mechanisms to silver and metal oxide nanomaterials.
Review in FEMS microbiology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Metal-Substituted Hydroxyapatite Nanoparticles as Antimicrobial and Osteogenic Biomaterials for Hard-Tissue Applications.Materials (Basel, Switzerland) · 2026Review
- Targeting Golgi-STING Signaling to Reprogram Innate and Adaptive Immunity for the Treatment of Implant-Associated Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Green-Synthesized vs. Chemical Silver Nanoparticles: A Comparative Study onMicroorganisms · 2026Article
- Multidrug Resistance and Adaptive Response to Silver and Gold Nanoparticles in Methicillin-ResistantPathogens (Basel, Switzerland) · 2026Article
- Nano-enabled disruption of bacterial virulence and communication in plant pathosystems: emerging strategies for sustainable disease management.Frontiers in plant science · 2026Review
- Nano-Modified Titanium Implant Surfaces for the Prevention and Treatment of Peri-Implantitis: A Review.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This review addresses the crucial and emerging field of bacterial adaptation to antimicrobial nanomaterials, challenging prior assumptions that their multi-level action prevents the development of reduced bacterial sensitivity. It provides a comprehensive overview of experimentally induced adaptation mechanisms across various nanomaterials (e.g. AgNPs, ZnO) and bacterial species. Bacterial adaptations encompass genetic adaptations (e.g. efflux systems, mutagenesis), biomolecule production (e.g. flagellin, exopolysaccharides forming biofilms, protein coronas), and structural changes (e.g. altered shape, cell wall thickening, enhanced motility, membrane permeability changes). The described adaptation mechanisms to nanomaterials are compared with antibiotic resistance mechanisms, emphasizing common strategies such as efflux and envelope changes, but also unique adaptations specific to nanoparticles, such as aggregation and different roles of biomolecules. The review offers insights and emerging strategies for designing safer, more effective nano-antimicrobials, including membrane potential disruption, biofilm inhibition, and size modulation. It emphasizes the need for standardized evaluation methods and future research on cross-resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.